Reuters: Health News
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.
United Therapeutics to develop, sell Arena Pharma's hypertension treatment
15 Nov 2018 at 4:58am
United Therapeutics Corp on Thursday signed a deal potentially worth up to $1.2 billion for the rights to develop and sell Arena Pharmaceuticals Inc's pulmonary arterial hypertension treatment(PAH).
Novartis 'completely committed' to Sandoz, has no split-off plan
15 Nov 2018 at 1:56am
Swiss drugmaker Novartis is "completely committed" to its $10 billion-per-year Sandoz generics business, a spokesman said on Thursday, after a newspaper reported Chief Executive Vas Narasimhan planned to split the unit off.
UK health service risks 350,000 staff gap by 2030: thinktanks
15 Nov 2018 at 1:18am
Lack of staff now represents a bigger challenge to Britain's health service than funding and the system could face a 350,000 personnel shortage by 2030, leading health thinktanks warned on Thursday.
China confirms new African swine fever outbreak in Hubei province
14 Nov 2018 at 11:22pm
China's agricultural ministry said on Thursday it had confirmed a new African swine fever outbreak near the city of Huangguang in the central province of Hubei.
Low emission zones improve city air, but not enough: study
14 Nov 2018 at 3:37pm
London's low emission traffic zone has modestly reduced residents' exposure to diesel engine pollution, but the better air quality has not brought improved lung health among the capital's children, research found on Wednesday.
Babies' brain development may not depend on sleeping through the night
14 Nov 2018 at 2:17pm
(Reuters Health) - Infants who don't sleep through the night don't seem to be at higher risk for cognitive or motor development problems, a Canadian study suggests.
Surgeons design inexpensive headlamp to make operations safer in poor conditions
14 Nov 2018 at 1:52pm
(Reuters Health) - Surgeries in poorer countries can become dangerous when electrical power goes out, as it often does.
Nitroglycerin patches may help ease tendon pain
14 Nov 2018 at 1:23pm
(Reuters Health) - Patches containing nitroglycerin may help patients with common injuries to tendons, a research review suggests.
Jury clears J&J of liability in California talc cancer case
14 Nov 2018 at 12:45pm
A California jury on Wednesday cleared Johnson & Johnson of liability in a case involving a woman who alleged that the company's talc-based products, including its baby powder, contain asbestos and caused her cancer, the company said.
Pfizer loses drug patent fight in UK top court, may face claims
14 Nov 2018 at 11:52am
Pfizer lost the final round in a lengthy patent battle in Britain on Wednesday after the country's highest court ruled against it in a case involving its $5 billion-a-year pain drug Lyrica, exposing the company to possible financial claims.
Stricter state gun laws linked to fewer child deaths from gunshot wounds
14 Nov 2018 at 10:10am
(Reuters Health) - Twice as many U.S. children die from gunshot wounds in states with lax gun laws, compared to those with stricter rules, researchers told the annual conference of the American Academy of Pediatrics in Orlando, Florida.
French pharma group Ipsen closes in on its next drug deals
14 Nov 2018 at 8:42am
French drugmaker Ipsen plans to bring in multiple new medicines through a series of transactions and sees the recent price drop of biotech stocks as increasing deal opportunities, its chief executive said on Wednesday.
Congo's Ebola outbreak to last at least six more months: WHO
14 Nov 2018 at 5:02am
The Ebola outbreak in northeastern Democratic Republic of Congo, which has already killed more than 200 people, is expected to last until mid-2019, a senior World Health Organization official said on Tuesday.
Merck drug Keytruda succeeds in late-stage esophageal cancer trial
14 Nov 2018 at 4:18am
Merck & Co's blockbuster drug Keytruda met the main goal of a late-stage trial testing the treatment in patients with cancers of the digestive tract, the U.S. drugmaker said on Wednesday.
German health minister calls for faster adoption of biosimilar drugs
14 Nov 2018 at 12:35am
Germany's health minister Jens Spahn has called for faster adoption of cheaper copies of biotech drugs to treat cancer and autoimmune diseases to reign in rising public healthcare costs.